BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/4/2025 8:55:22 AM | Browse: 8 | Download: 20
Publication Name World Journal of Biological Chemistry
Manuscript ID 111258
Country United States
Received
2025-06-26 04:04
Peer-Review Started
2025-06-26 04:04
First Decision by Editorial Office Director
2025-07-08 07:02
Return for Revision
2025-07-08 07:02
Revised
2025-07-15 02:51
Publication Fee Transferred
2025-07-16 19:43
Second Decision by Editor
2025-10-10 02:40
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-10-10 09:59
Articles in Press
2025-10-10 09:59
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-10-30 00:25
Publish the Manuscript Online
2025-12-04 06:40
ISSN 1949-8454 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biochemistry & Molecular Biology
Manuscript Type Review
Article Title Molecular and cellular mechanisms of pentadecanoic acid
Manuscript Source Unsolicited Manuscript
All Author List Joseph Mercola
Funding Agency and Grant Number
Corresponding Author Joseph Mercola, Researcher, . drm@mercola.com
Key Words Pentadecanoic acid; Peroxisome proliferator activated receptors; Adenosine monophosphate activated protein kinase; Mitochondrial bioenergetics; Histone deacetylase six inhibition; Anti-inflammatory signaling; Odd chain saturated fatty acids; Metabolic health; Nutraceutical potential
Core Tip Pentadecanoic acid (C15:0) is portrayed as the first essential odd-chain saturated fat that ignites fat-burning through partial peroxisome proliferator-activated receptor α/δ agonism, activates AMP-activated protein kinase while damping mechanistic target of rapamycin, revives complex II via succinate anaplerosis, and uniquely inhibits cancer-linked histone deacetylase 6. It also blocks Janus kinase 2/signal transducer and activator of transcription 3 and nuclear factor kappa B, using the BioMAP® human-primary-cell platform – which tests 12 distinct primary human cell systems such as endothelial cells, fibroblasts, macrophages, and T-cells – C15:0 (17 µM) produced statistically significant changes in 36 mechanistically diverse biomarkers. By eliciting broad, multi-pathway modulation that mirrors the phenotype produced by metformin and rapamycin – yet with no detectable cytotoxicity – C15:0 emerges as a safe, affordable “nutrapharmaceutical” poised to counter metabolic, inflammatory, and age-related diseases.
Publish Date 2025-12-04 06:40
Citation

Mercola J. Molecular and cellular mechanisms of pentadecanoic acid. World J Biol Chem 2025; 16(4): 111258

URL https://www.wjgnet.com/1949-8454/full/v16/i4/111258.htm
DOI https://dx.doi.org/10.4331/wjbc.v16.i4.111258
Full Article (PDF) WJBC-16-111258-with-cover.pdf
Manuscript File 111258_Auto_Edited_102750.docx
Answering Reviewers 111258-answering-reviewers.pdf
Audio Core Tip 111258-audio.mp3
Conflict-of-Interest Disclosure Form 111258-conflict-of-interest-statement.pdf
Copyright License Agreement 111258-copyright-assignment.pdf
Peer-review Report 111258-peer-reviews.pdf
Scientific Misconduct Check 111258-scientific-misconduct-check.png
Scientific Editor Work List 111258-scientific-editor-work-list.pdf
CrossCheck Report 111258-crosscheck-report.pdf